Ingredients

Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention

Could dry vaccines help improve global access to the latest vaccine technologies?

Old photos, newspaper clippings, and more tell the origin story of a major product line

Watch our special roundtable to learn about pharma industry trends and events post-COVID-19.

From chasing drug lords to advising US presidents, it’s fair to say Robert Pinco has enjoyed a varied career.

Keith Horspool reflects on the efforts that led the FDA to launch its pilot review program for novel excipients

As new treatment modalities emerge, drug developers are turning to synthetic chemistry – and partners like Veranova.

We interview Chris Moreton to find out more about his career and why formulation is such a fascinating area to pursue.

Environmentally friendly catalyst technologies are on the rise in pharma.

What difference can taste-masking make to the patient experience?